EE9700225A - Meetod diabetes mellituse raviks, kasutades KKF - Google Patents

Meetod diabetes mellituse raviks, kasutades KKF

Info

Publication number: EE9700225A
Authority: EE; Estonia
Prior art keywords: kkf; diabetes mellitus; treating diabetes; mammals; pharmaceutical compositions
Prior art date: 1994-10-13

Application number

EE9700225A

Other languages

English (en)

Estonian (et)

Inventor

Francis Pierce Glenn

Lea Aukerman Sharon

Original Assignee

Amgen Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-10-12

Publication date

1998-02-16

1995-10-12 Application filed by Amgen Inc. filed Critical Amgen Inc.

1998-02-16 Publication of EE9700225A publication Critical patent/EE9700225A/xx

Links

206010012601 diabetes mellitus Diseases 0.000 title abstract 2
102000003972 Fibroblast growth factor 7 Human genes 0.000 abstract 1
108090000385 Fibroblast growth factor 7 Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Zoology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EE9700225A 1994-10-13 1995-10-12 Meetod diabetes mellituse raviks, kasutades KKF EE9700225A (et)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US32334094A	1994-10-13	1994-10-13
US32347594A	1994-10-13	1994-10-13
US48782595A	1995-06-07	1995-06-07
PCT/IB1995/000992 WO1996011950A1 (en)	1994-10-13	1995-10-12	Method of treating diabetes mellitus using kgf

Publications (1)

Publication Number	Publication Date
EE9700225A true EE9700225A (et)	1998-02-16

Family

ID=27406268

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EE9700225A EE9700225A (et)	1994-10-13	1995-10-12	Meetod diabetes mellituse raviks, kasutades KKF
EE9700081A EE03975B1 (et)	1994-10-13	1995-10-12	Keratinotsüüdi kasvufaktori analoogid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EE9700081A EE03975B1 (et)	1994-10-13	1995-10-12	Keratinotsüüdi kasvufaktori analoogid

Country Status (23)

Country	Link
EP (2)	EP0804479B1 (pt)
JP (2)	JP4216329B2 (pt)
KR (1)	KR100278597B1 (pt)
CN (1)	CN1168678A (pt)
AT (2)	ATE342278T1 (pt)
AU (1)	AU3707795A (pt)
BG (2)	BG101392A (pt)
BR (2)	BR9509269A (pt)
CA (2)	CA2201940C (pt)
CZ (3)	CZ98197A3 (pt)
DE (2)	DE69535264T2 (pt)
DK (2)	DK0804479T3 (pt)
EE (2)	EE9700225A (pt)
ES (2)	ES2196082T3 (pt)
FI (2)	FI971420A0 (pt)
HU (2)	HU226168B1 (pt)
NO (2)	NO971566L (pt)
NZ (2)	NZ505502A (pt)
PL (2)	PL182888B1 (pt)
PT (2)	PT804479E (pt)
SI (2)	SI0804479T1 (pt)
SK (2)	SK284534B6 (pt)
WO (2)	WO1996011949A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69033668T2 (de)	1989-01-31	2001-04-12	Jeffrey S Rubin	Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
DE69434053T2 (de)	1993-06-29	2006-02-23	Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville	Verkürzter keratinocytenwachstumsfaktor(kgf)mit erhöhter biologischer aktivität
US7084119B2 (en)	1993-06-29	2006-08-01	Chiron Corporation	Truncated keratinocyte growth factor (KGF) having increased biological activity
CN1161380C (zh) *	1994-10-13	2004-08-11	安姆根有限公司	角化细胞生长因子的纯化方法
US6077692A (en)	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
EP0822943B9 (en) *	1995-04-27	2007-02-28	Coöperatie Cosun U.A.	Inulin derivatives
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
EP0935652B1 (en) *	1996-10-15	2004-03-31	Amgen Inc.	Keratinocyte growth factor-2 products
SI0935652T1 (en) *	1996-10-15	2004-06-30	Amgen Inc.	Keratinocyte growth factor-2 products
US7153943B2 (en)	1997-07-14	2006-12-26	Bolder Biotechnology, Inc.	Derivatives of growth hormone and related proteins, and methods of use thereof
US7495087B2 (en)	1997-07-14	2009-02-24	Bolder Biotechnology, Inc.	Cysteine muteins in the C-D loop of human interleukin-11
US20080076706A1 (en)	1997-07-14	2008-03-27	Bolder Biotechnology, Inc.	Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
DE69838552T2 (de)	1997-07-14	2008-05-21	Bolder Biotechnology, Inc., Louisville	Derivate des wachstumshormons und verwandte proteine
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
CA2316015A1 (en)	1997-12-22	1999-07-01	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
US6242666B1 (en)	1998-12-16	2001-06-05	The Scripps Research Institute	Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
ATE526401T1 (de) *	1999-01-14	2011-10-15	Bolder Biotechnology Inc	Verfahren zur herstellung von proteinen mit freien cysteinresten
US8288126B2 (en)	1999-01-14	2012-10-16	Bolder Biotechnology, Inc.	Methods for making proteins containing free cysteine residues
US6248725B1 (en)	1999-02-23	2001-06-19	Amgen, Inc.	Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
WO2002062842A1 (en) *	2001-02-06	2002-08-15	Merck Patent Gmbh	Modified keratinocyte growth factor (kgf) with reduced immunogenicity
MXPA04001526A (es)	2001-08-21	2004-05-31	Chiron Corp	Composiciones de polipetidos kgf.
AU2007214362B2 (en) *	2001-08-21	2009-11-26	Novartis Vaccines And Diagnostics, Inc.	KGF polypeptide compositions
SI1827483T1 (sl)	2004-12-15	2014-11-28	Swedish Orphan Biovitrum Ab (Publ)	Terapevtske formulacije keratinocitnega rastnega faktorja
CN102242124B (zh) *	2010-05-10	2013-05-22	齐鲁制药有限公司	改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) *	2020-08-28	2022-09-05	한국해양과학기술원	온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4959314A (en) *	1984-11-09	1990-09-25	Cetus Corporation	Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) *	1987-08-10	1989-05-30	Shionogi & Co Ltd	ｒｅｇ蛋白質
WO1990000877A1 (en) *	1988-07-27	1990-02-08	Marjan International Pty Ltd	Carpet stretcher
DE69033668T2 (de) *	1989-01-31	2001-04-12	Jeffrey S Rubin	Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
JP3303211B2 (ja) *	1991-04-26	2002-07-15	武田薬品工業株式会社	ｂＦＧＦムテインおよびその製造法
CN1064710C (zh) *	1993-03-26	2001-04-18	安姆根有限公司	角质细胞生长因子的治疗应用
US5348563A (en) *	1993-06-29	1994-09-20	Honeywell Inc.	Air purifying apparatus
DE69434053T2 (de) *	1993-06-29	2006-02-23	Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville	Verkürzter keratinocytenwachstumsfaktor(kgf)mit erhöhter biologischer aktivität
GB9315501D0 (en) *	1993-07-27	1993-09-08	Ici Plc	Surfactant compositions
WO1995003831A1 (en) *	1993-08-02	1995-02-09	Prizm Pharmaceuticals, Inc.	Monogenous preparations of cytotoxic conjugates

1995
- 1995-10-12 SI SI9530728T patent/SI0804479T1/sl unknown
- 1995-10-12 DK DK95934808T patent/DK0804479T3/da active
- 1995-10-12 PT PT95934808T patent/PT804479E/pt unknown
- 1995-10-12 SK SK455-97A patent/SK284534B6/sk not_active IP Right Cessation
- 1995-10-12 JP JP51307796A patent/JP4216329B2/ja not_active Expired - Fee Related
- 1995-10-12 WO PCT/IB1995/000971 patent/WO1996011949A2/en active IP Right Grant
- 1995-10-12 AT AT95934808T patent/ATE342278T1/de active
- 1995-10-12 BR BR9509269A patent/BR9509269A/pt not_active Application Discontinuation
- 1995-10-12 CN CN95196410A patent/CN1168678A/zh active Pending
- 1995-10-12 BR BR9509329A patent/BR9509329A/pt not_active Application Discontinuation
- 1995-10-12 WO PCT/IB1995/000992 patent/WO1996011950A1/en active IP Right Grant
- 1995-10-12 HU HU9901255A patent/HU226168B1/hu not_active IP Right Cessation
- 1995-10-12 SK SK431-97A patent/SK43197A3/sk unknown
- 1995-10-12 DE DE69535264T patent/DE69535264T2/de not_active Expired - Lifetime
- 1995-10-12 AT AT95934793T patent/ATE237633T1/de active
- 1995-10-12 ES ES95934793T patent/ES2196082T3/es not_active Expired - Lifetime
- 1995-10-12 NZ NZ505502A patent/NZ505502A/en not_active IP Right Cessation
- 1995-10-12 DK DK95934793T patent/DK0785948T3/da active
- 1995-10-12 HU HU9901071A patent/HUT78050A/hu unknown
- 1995-10-12 SI SI9530654T patent/SI0785948T1/xx unknown
- 1995-10-12 EP EP95934808A patent/EP0804479B1/en not_active Expired - Lifetime
- 1995-10-12 EP EP95934793A patent/EP0785948B1/en not_active Expired - Lifetime
- 1995-10-12 EE EE9700225A patent/EE9700225A/xx unknown
- 1995-10-12 KR KR1019970702343A patent/KR100278597B1/ko not_active IP Right Cessation
- 1995-10-12 CA CA002201940A patent/CA2201940C/en not_active Expired - Fee Related
- 1995-10-12 CZ CZ97981A patent/CZ98197A3/cs unknown
- 1995-10-12 EE EE9700081A patent/EE03975B1/xx not_active IP Right Cessation
- 1995-10-12 AU AU37077/95A patent/AU3707795A/en not_active Abandoned
- 1995-10-12 CZ CZ0105097A patent/CZ297328B6/cs not_active IP Right Cessation
- 1995-10-12 JP JP51307696A patent/JP4426646B2/ja not_active Expired - Fee Related
- 1995-10-12 PL PL95319784A patent/PL182888B1/pl not_active IP Right Cessation
- 1995-10-12 ES ES95934808T patent/ES2273338T3/es not_active Expired - Lifetime
- 1995-10-12 CA CA002202075A patent/CA2202075C/en not_active Expired - Fee Related
- 1995-10-12 PL PL95320484A patent/PL320484A1/xx unknown
- 1995-10-12 DE DE69530403T patent/DE69530403T2/de not_active Expired - Lifetime
- 1995-10-12 PT PT95934793T patent/PT785948E/pt unknown
- 1995-10-12 CZ CZ20023953A patent/CZ297329B6/cs not_active IP Right Cessation
1997
- 1997-04-04 NO NO971566A patent/NO971566L/no unknown
- 1997-04-04 FI FI971420A patent/FI971420A0/fi unknown
- 1997-04-04 NO NO19971568A patent/NO318761B1/no not_active IP Right Cessation
- 1997-04-07 BG BG101392A patent/BG101392A/xx unknown
- 1997-04-11 BG BG101408A patent/BG63167B1/bg unknown
- 1997-04-11 FI FI971536A patent/FI120040B/fi not_active IP Right Cessation
1999
- 1999-04-09 NZ NZ335109A patent/NZ335109A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL182888B1 (pl)	2002-03-29
ATE342278T1 (de)	2006-11-15
ES2273338T3 (es)	2007-05-01
NO971566L (no)	1997-04-14
HU226168B1 (en)	2008-05-28
DE69535264T2 (de)	2007-02-01
SI0785948T1 (en)	2003-08-31
PT804479E (pt)	2007-02-28
BG101408A (en)	1997-12-30
DK0804479T3 (da)	2007-01-29
CZ297328B6 (cs)	2006-11-15
EP0785948A1 (en)	1997-07-30
NO971568L (no)	1997-06-12
AU3707795A (en)	1996-05-06
CA2202075C (en)	2003-12-09
EP0785948B1 (en)	2003-04-16
FI971536A (fi)	1997-06-09
NZ335109A (en)	2000-08-25
JPH10507193A (ja)	1998-07-14
FI971420A (fi)	1997-04-04
WO1996011949A3 (en)	1996-12-12
EP0804479A1 (en)	1997-11-05
SK43197A3 (en)	1999-03-12
CA2201940C (en)	2009-05-12
ATE237633T1 (de)	2003-05-15
CZ297329B6 (cs)	2006-11-15
JPH10507080A (ja)	1998-07-14
ES2196082T3 (es)	2003-12-16
PT785948E (pt)	2003-09-30
BR9509329A (pt)	1997-10-14
CA2201940A1 (en)	1996-04-25
DE69530403T2 (de)	2003-10-30
PL319784A1 (en)	1997-08-18
SK284534B6 (sk)	2005-06-02
CA2202075A1 (en)	1996-04-25
WO1996011950A1 (en)	1996-04-25
NO971566D0 (no)	1997-04-04
SK45597A3 (en)	1999-02-11
DE69530403D1 (de)	2003-05-22
FI971536A0 (fi)	1997-04-11
WO1996011949A2 (en)	1996-04-25
AU3708395A (en)	1996-05-06
KR100278597B1 (ko)	2001-01-15
FI971420A0 (fi)	1997-04-04
SI0804479T1 (sl)	2006-12-31
HUT78050A (hu)	1999-07-28
NZ505502A (en)	2005-01-28
DK0785948T3 (da)	2003-08-04
CN1168678A (zh)	1997-12-24
PL320484A1 (en)	1997-09-29
BR9509269A (pt)	1997-12-23
NO318761B1 (no)	2005-05-02
JP4216329B2 (ja)	2009-01-28
BG63167B1 (bg)	2001-05-31
BG101392A (en)	1997-10-31
NO971568D0 (no)	1997-04-04
DE69535264D1 (de)	2006-11-23
EP0804479B1 (en)	2006-10-11
EE03975B1 (et)	2003-02-17
HUT78058A (hu)	1999-07-28
JP4426646B2 (ja)	2010-03-03
EE9700081A (et)	1997-10-15
FI120040B (fi)	2009-06-15
CZ105097A3 (cs)	1998-10-14
CZ98197A3 (cs)	1998-11-11
AU681546B2 (en)	1997-08-28

Publication	Publication Date	Title
EE9700225A (et)	1998-02-16	Meetod diabetes mellituse raviks, kasutades KKF
DE69027865D1 (de)	1996-08-22	ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
TR200100922T2 (tr)	2001-09-21	Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
AU5624699A (en)	2000-03-21	Use of 5ht-6 antagonists
BG102616A (en)	1999-04-30	Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
MX9704050A (es)	1997-08-30	P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
FR2491334B1 (pt)	1983-09-23
ATE234614T1 (de)	2003-04-15	Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE251462T1 (de)	2003-10-15	Verfahren zur behandlung von narbengewebe
ATE129712T1 (de)	1995-11-15	Substituierte pyrido-oxazine.
ES2153584T3 (es)	2001-03-01	Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
DE69734349D1 (de)	2006-02-23	Behandlung von knochenleiden mit adrenomedullin
DE69409961T2 (de)	1998-09-10	Triarylethylenderivate zur therapeutischen verwendung
DE69110861D1 (de)	1995-08-03	Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.
UA15363A (uk)	1997-06-30	Засіб для лікуваhhя відкритих пошкоджеhь